Rhythm Pharmaceuticals Stock Analysis

Rhythm Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.75. Rhythm Pharmaceuticals recorded a loss per share of 4.32. The entity had not issued any dividends in recent years. Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. Rhythm Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 140 people. To find out more about Rhythm Pharmaceuticals contact the company at 857 264 4280 or learn more at https://rhythmtx.com.

Rhythm Pharmaceuticals Investment Alerts

Rhythm Pharmaceuticals Upcoming and Recent Events

Rhythm Largest EPS Surprises

View All Earnings Estimates

Rhythm Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Rhythm Stock Institutional Investors

Note, although Rhythm Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Rhythm Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.81 B.

Rhythm Profitablity

The company has Profit Margin (PM) of (2.3) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.32) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.32.

Management Efficiency

Rhythm Pharmaceuticals has return on total asset (ROA) of (0.4624) % which means that it has lost $0.4624 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.479) %, meaning that it created substantial loss on money invested by shareholders. Rhythm Pharmaceuticals' management efficiency ratios could be used to measure how well Rhythm Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of November 2024, Return On Tangible Assets is likely to drop to -0.6. In addition to that, Return On Capital Employed is likely to grow to -0.63. At this time, Rhythm Pharmaceuticals' Non Current Assets Total are very stable compared to the past year. As of the 30th of November 2024, Non Currrent Assets Other is likely to grow to about 16.1 M, while Other Current Assets are likely to drop about 5.8 M.

Technical Drivers

As of the 30th of November, Rhythm Pharmaceuticals holds the Semi Deviation of 2.34, risk adjusted performance of 0.126, and Coefficient Of Variation of 645.62. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rhythm Pharmaceuticals, as well as the relationship between them. Please check Rhythm Pharmaceuticals market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Rhythm Pharmaceuticals is priced some-what accurately, providing market reflects its current price of 62.04 per share. Given that Rhythm Pharmaceuticals has jensen alpha of 0.2366, we recommend you to check out Rhythm Pharmaceuticals's recent market performance to make sure the company can sustain itself at a future point.

Rhythm Pharmaceuticals Price Movement Analysis

Rhythm Pharmaceuticals Insider Trading Activities

Rhythm Pharmaceuticals Outstanding Bonds

Rhythm Pharmaceuticals Predictive Daily Indicators

Rhythm Pharmaceuticals Corporate Filings

Rhythm Pharmaceuticals Forecast Models

Rhythm Pharmaceuticals' time-series forecasting models are one of many Rhythm Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Rhythm Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Rhythm Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Rhythm shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Rhythm Pharmaceuticals. By using and applying Rhythm Stock analysis, traders can create a robust methodology for identifying Rhythm entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Rhythm analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Rhythm analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Rhythm Pharmaceuticals stock analysis indicators help investors evaluate how Rhythm Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Rhythm Pharmaceuticals shares will generate the highest return on investment. By understating and applying Rhythm Pharmaceuticals stock analysis, traders can identify Rhythm Pharmaceuticals position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rhythm Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rhythm Pharmaceuticals. If investors know Rhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rhythm Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Rhythm Pharmaceuticals is measured differently than its book value, which is the value of Rhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Rhythm Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rhythm Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rhythm Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rhythm Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Rhythm Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rhythm Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rhythm Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.